TELA Bio Income Statement (2018-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	7.65M	8.37M	8.23M	10.41M	11.16M	11.62M	11.91M	14.49M	15.05M	17.00M	16.60M	16.09M	18.96M	17.65M	18.52M	20.20M	20.69M	20.87M	19.06M	19.29M
Cost of Revenue (Quarter)	2.98M	2.64M	3.16M	3.32M	3.75M	3.35M	3.92M	4.20M	4.57M	5.28M	5.17M	4.92M	6.00M	6.33M	5.91M	6.00M	6.62M	7.02M	6.44M	5.25M
Gross Profit (Quarter)	4.60M	5.66M	5.00M	6.55M	7.32M	8.18M	7.90M	10.20M	10.39M	11.62M	11.34M	11.07M	12.86M	11.22M	12.51M	14.11M	13.97M	13.76M	12.52M	13.94M
Operating items
Amortization - Intangibles (Quarter)	0.08M	0.07M	0.08M	0.54M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M
Research & Development (Quarter)	6.95M	1.73M	2.01M	11.05M	2.10M	11.65M	2.05M	2.51M	14.47M	17.16M	2.39M	2.32M	2.07M	13.96M	16.61M	16.86M	15.23M	56.09M	16.54M	16.44M
Selling, General & Administrative (Quarter)	3.46M	3.27M	3.46M	3.63M	3.53M	3.24M	3.63M	3.47M	3.73M	4.05M	3.83M	3.62M	3.68M	3.59M	3.84M	4.13M	3.95M	3.78M	4.17M	4.06M
Restructuring Costs (Quarter)											1.81M	1.78M	1.80M	1.83M	1.89M	2.16M	2.11M	2.08M	2.14M	2.06M
Other Operating Expenses (Quarter)	1.41M	8.31M	9.38M	2.10M	11.17M	2.73M	13.47M	14.58M	2.37M	2.69M	7.60M	-0.02M			0.66M	0.04M	0.24M	-41.56M	0.20M	0.66M
Operating Expenses (Quarter)	11.82M	13.31M	14.84M	16.79M	16.81M	17.61M	19.15M	20.56M	20.57M	23.90M	23.74M	22.64M	22.22M	19.57M	22.98M	23.19M	21.52M	20.40M	23.05M	23.23M
Operating Income (Quarter)	-7.22M	-7.65M	-9.84M	-10.24M	-9.49M	-9.44M	-11.25M	-10.36M	-10.18M	-12.28M	-4.83M	-11.57M	-9.37M	-8.35M	-10.47M	-9.08M	-7.55M	-6.65M	-10.53M	-9.28M
EBIT (Quarter)	-7.22M	-7.65M	-9.84M	-10.24M	-9.49M	-9.44M	-11.25M	-10.36M	-10.18M	-12.28M	-4.83M	-11.57M	-9.37M	-8.35M	-10.47M	-9.08M	-7.55M	-6.65M	-10.53M	-9.28M
Non-operating items
Other Non Operating Income (Quarter)	-0.13M	-0.04M	-0.11M	-0.34M	-0.20M	1.22M	0.47M	0.87M	0.56M	0.73M	0.50M	0.30M	0.34M	0.28M	0.48M	0.38M	0.15M	-0.80M	0.37M	0.16M
Non Operating Income (Quarter)	-1.05M	-0.96M	-1.02M	-2.50M	-1.23M	-0.54M	-0.77M	-0.43M	-0.78M	-0.61M	-0.83M	-1.03M	-1.01M	-1.00M	-0.74M	-0.81M	-1.05M	-2.25M	-1.69M	-1.92M
Net income details
EBT (Quarter)	-11.32M	-7.89M	-11.18M	-11.17M	-10.69M	-9.16M	-12.50M	-12.36M	-11.52M	-14.05M	-5.66M	-12.60M	-10.37M	29.25M	-11.21M	-9.89M	-8.60M	-8.90M	-12.21M	-11.20M
Tax Provisions (Quarter)															0.05M	0.03M		0.00M	0.06M	0.06M
Profit After Tax (Quarter)	-8.27M	-8.62M	-10.86M	-12.74M	-10.71M	-9.98M	-12.06M	-10.79M	-10.96M	-12.88M	-5.66M	-12.60M	-10.32M	-9.21M	-11.26M	-9.92M	-8.60M	-9.04M	-12.27M	-11.26M
Income from Continuing Operations (Quarter)	-11.32M	-7.89M	-11.18M	-11.17M	-10.69M	-9.16M	-12.50M	-12.36M	-11.52M	-14.05M	-5.66M	-12.60M	-10.37M	29.25M	-11.26M	-9.92M	-8.60M	-8.90M	-12.27M	-11.26M
Consolidated Net Income (Quarter)	-11.32M	-7.89M	-11.18M	-11.17M	-10.69M	-9.16M	-12.50M	-12.36M	-11.52M	-14.05M	-5.66M	-12.60M	-10.37M	29.25M	-11.26M	-9.92M	-8.60M	-8.90M	-12.27M	-11.26M
Income towards Parent Company (Quarter)	-11.32M	-7.89M	-11.18M	-11.17M	-10.69M	-9.16M	-12.50M	-12.36M	-11.52M	-14.05M	-5.66M	-12.60M	-10.37M	29.25M	-11.26M	-9.92M	-8.60M	-8.90M	-12.27M	-11.26M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-11.32M	-7.89M	-11.18M	-11.17M	-10.69M	-9.16M	-12.50M	-12.36M	-11.52M	-14.05M	-5.66M	-12.60M	-10.37M	29.25M	-11.26M	-9.92M	-8.60M	-8.90M	-12.27M	-11.26M
Additional items
EPS (Basic) (Quarter)	-0.78	-0.54	-0.77	-0.77	-0.64	-0.56	-0.65	-0.53	-0.47	-0.61	-0.23	-0.51	-0.42	1.03	-0.25	-0.22	-0.19	-0.19	-0.21	-0.20
EPS (Diluted) (Quarter)	-0.78	-0.54	-0.77	-0.77	-0.64	-0.56	-0.65	-0.53	-0.47	-0.61	-0.23	-0.51	-0.42	1.03	-0.25	-0.22	-0.19	-0.19	-0.21	-0.20
Shares Outstanding (Quarter)	14.49M	14.47M	14.54M	14.56M	16.76M	16.27M	19.19M	23.24M	24.48M	22.87M	24.58M	24.66M	24.70M	28.53M	45.27M	45.37M	45.42M	46.95M	57.26M	57.41M
Shares Outstanding (Diluted) (Quarter)	14.49M	14.47M	14.54M	14.56M	16.76M	16.27M	19.19M	23.24M	24.48M	22.87M	24.58M	24.66M	24.70M	28.53M	45.27M	45.37M	45.42M	46.95M	57.26M	57.41M
Shares Outstanding (Entity) (Quarter)	14.50M	14.53M	14.56M	14.56M	19.16M	19.17M	19.23M	24.48M	24.49M	24.49M	24.65M	24.68M	24.72M	28.53M	39.55M	39.58M	40.34M	44.54M	57.26M	57.41M
EBITDA (Quarter)	-7.22M	-7.65M	-9.84M	-10.24M	-9.49M	-9.44M	-11.25M	-10.36M	-10.18M	-12.28M	-4.83M	-11.57M	-9.37M	-8.35M	-10.47M	-9.08M	-7.55M	-6.65M	-10.53M	-9.28M
Interest Expenses (Quarter)	4.10M	0.23M	1.33M	0.93M	1.20M	-0.28M	1.25M	2.00M	1.33M	1.77M	1.33M	1.33M	1.34M	1.75M	1.37M	1.20M	1.20M	0.50M	2.10M	2.10M
Tax Rate (Quarter)															-0.46%	-0.33%		-0.01%	-0.49%	-0.54%

Research Tools

Datasets

Plans

Developers

TELA Bio TELA Income Statement (2018-2026)

Research Tools

Datasets

Plans

Developers

TELA Bio TELA Income Statement (2018-2026)

Create an account

Sign In

Reset Password